¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Anaemia due to enzyme disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • extracellular enzyme
    ¼¼Æ÷¿ÜÈ¿¼Ò
  • enzyme
    È¿¼Ò
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • enzyme assay
    È¿¼ÒÃøÁ¤
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme inhibition
    È¿¼Ò¾ïÁ¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • enzyme labeled antibody
    È¿¼ÒÇ¥ÁöÇ×ü
  • enzyme labeling
    È¿¼ÒÇ¥Áö
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • enzyme precursor
    È¿¼ÒÀü±¸¹°Áú
  • enzyme-antibody conjugate
    È¿¼ÒÇ×üÁ¢ÇÕü
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
  • enzyme-linked immunoelectrotransfer blot
    È¿¼Ò°áÇո鿪ÀÌÀû¹ý, È¿¼Ò¿¬°ü¸é¿ªÀü±âÀü´Þ¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò°áÇո鿪ÈíÂøÃøÁ¤(¹ý)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • curdling enzyme
    ÀÀÀ¯È¿¼Ò
  • cytosolic enzyme
    ¼¼Æ÷ÁúÈ¿¼Ò
  • enzyme-antibody conjugate
    È¿¼ÒÇ×üÁ¢ÇÕü
  • debrancher enzyme
    °¡ÁöÁ¦°ÅÈ¿¼Ò
  • degumming enzyme
    ÇØ±³È¿¼Ò
  • diastatic enzyme
    ´çÈ­È¿¼Ò
  • digestive enzyme
    ¼ÒÈ­È¿¼Ò
  • enzyme
    È¿¼Ò
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme inhibition
    È¿¼Ò¾ïÁ¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • enzyme labeling
    È¿¼ÒÇ¥Áö
  • enzyme precursor
    È¿¼ÒÀü±¸Ã¼
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • enzyme trace substance theory
    È¿¼ÒÈçÀû¹°¼³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ELISA => enzyme-linked immunosorbent assay
    ¿¤¶óÀÌÀÚ
  • EMMIA => enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªÃøÁ¤
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò(îêëëý£áÈ).
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò(¡­ý£áÈ).
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò.
  • angiotensin converting enzyme inbibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • antibody, enzyme-labelled
    È¿¼ÒÇ¥ÁöÇ×ü
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò.
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ<--Áú>È¿¼Ò¸é¿ªÇÐÀûÃøÁ¤(¹ý)
  • homogeneous enzyme immunoassay
    ±ÕÁúÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • induced enzyme
    À¯µµÈ¿¼Ò.
  • inducible enzyme
    À¯µµ(¹ß)È¿¼Ò.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • larynx, congenital disorders of the
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • mendelian disorders
    ¸àµ¨ À¯Àü¼º Áúȯ(¡­ë¶îîàõ òðü´)
  • monoarticular disorders
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • movement disorders
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
  • neuroleptic-induced disorders
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • branching enzyme
    "ºÐÁöÈ¿¼Ò(ÝÂò«ý£áÈ), °¡ÁöÄ¡±â È¿¼Ò(ý£áÈ)"
  • breakage-reunion enzyme
    Àý´ÜÀç°áÇÕ È¿¼Ò(ï·Ó¨î¢Ì¿ùêý£áÈ)
  • CCA-enzyme
    CCA È¿¼Ò(ý£áÈ)
  • citrate cleavage enzyme
    ½ÃÆ®¸£»êÀý´ÜÈ¿¼Ò(ï·Ó¨ý£áÈ)
  • cold-sensitive enzyme
    ³Ã¹Î°¨ È¿¼Ò(Ò²ÚÂÊïý£áÈ)
  • clod-stable enzyme
    ³Ã¾ÈÁ¤ È¿¼Ò(Ò²äÌïÒý£áÈ)
  • condensing enzyme
    ÃàÇÕÈ¿¼Ò(õêùêý£áÈ)
  • conjugated enzyme
    Á¢ÇÕÈ¿¼Ò(ïÈùêý£áÈ)
  • constitutive enzyme
    ±¸¼ºÈ¿¼Ò(ϰà÷ý£áÈ)
  • converter enzyme
    Àüȯȿ¼Ò(ï®üµý£áÈ)
  • converting enzyme
    "Àüȯ È¿¼Ò(ï®üµý£áÈ), (ÔÒ) serum converting enzyme"
  • coordinated enzyme
    µ¿Á¶È¿¼Ò(ÔÒðàý£áÈ)
  • coordinated enzyme synthesis
    µ¿Á¶È¿¼ÒÇÕ¼º(ÔÒðàý£áÈùêà÷)
  • core enzyme
    ÇÙ½ÉÈ¿¼Ò(ú·ãýý£áÈ)
  • covalent enzyme-substrate complex
    È¿¼Ò±âÁú °øÀ¯°áÇÕü(ý£áÈÐñòõÍìêóÌ¿ùêô÷) (ÔÒ) enzymesubstrate compound
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DUE drug use evaluation
EDD effective drug duration; electron dense deposit; end-diastolic dimension; esophageal detection devic...
HSAS hydrocephalus due to stenosis of aqueduct of Sylvius; hypertrophic subaortic stenosis
ASDC Association of Sleep Disorders Centers; ¹Ì±¹ ¼ö¸é Áúȯ ¼¾ÅÍ Çùȸ
DIMS Disorders of Initiating & Maintaining Sleep; ÀÔ¸éÀå¾Ö ¹× ¼ö¸é À¯Áö Àå¾Ö; ºÒ¸éÁõ
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AHA autoimmune haemolytic anaemia
CAV Chicken Anaemia Virus
CAA Chicken anaemia agent
CDA II Congenital dyserythropoietic anaemia type II
DBA Diamond Blackfan Anaemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • enzyme-linked immunosorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
  • flavin enzyme
    Çöóºó È¿¼Ò
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ È¿¼Ò ¸é¿ªÇÐÀû ÃøÁ¤, ºÒ±ÕÀÏ È¿¼Ò ¸é¿ªÇÐÀû ÃøÁ¤¹ý
  • induced enzyme
    À¯µµ È¿¼Ò
    ±âÁú ¶Ç´Â ±×¿Í ±¸Á¶ÀûÀ¸·Î ¿¬°üµÈ, À¯µµ ¹°ÁúÀÇ Àڱؿ¡ ÀÇÇÏ¿© »ý¼ºµÈ È¿¼Ò.
  • lipolytic enzyme
    Áö¹æ ºÐÇØ È¿¼Ò
  • lysosomal enzyme
    ¸®¼ÒÁ» È¿¼Ò, ¿ëÇØ ¼Òü È¿¼Ò
  • microsomal enzyme
    ¹Ì¼Òü È¿¼Ò
  • microsomal enzyme system
    ¹Ì¼Òü È¿¼Ò°è
  • neural enzyme system
    ½Å°æ È¿¼Ò°è
  • pancreatic enzyme
    Ãé È¿¼Ò
    ÃéÀå¿¡¼­ ºÐºñµÇ´Â ź¼öÈ­¹°, Áö¹æ, ´Ü¹éÁúÀ» ºÐÇØÇÏ´Â È¿¼Ò.
  • periplasmic enzyme
    ¿øÇüÁú¸· ÁÖÀ§ °ø°£ È¿¼Ò
  • phosphorylating enzyme
    ÀλêÈ­ È¿¼Ò
  • proteolytic enzyme
    ´Ü¹é ºÐÇØ È¿¼Ò
    ´Ü¹é ºÐÇØ¸¦ ÃËÁøÇÏ´Â È¿¼Ò.
  • Q enzyme
    Å¥ È¿¼Ò
    Æ÷µµ´ç-1-ÀλêÀÇ 1,6-C¿¡ ÀÛ¿ëÇÏ¿© À̰ÍÀ» ÁßÈ­½ÃŰ´Â È¿¼Ò.
  • rate-limiting enzyme
    ¼Óµµ Á¶Àý È¿¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
paranoid disorders Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behaviour are consistent with the delusional state.
(12 Dec 1998)
rehabilitation of speech and language disorders Procedures for assisting a person with a speech or language disorder to communicate with maximum efficiency.
(12 Dec 1998)
vision disorders Visual impairment limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, colour vision, or peripheral vision. Visual disability refers to inability of the individual to perform specific visual tasks, such as reading, writing, orientation, or traveling unaided. It is to be differentiated from eye diseases which are restricted to diseases of the eye, the organ and its anatomical parts.
(12 Dec 1998)
voice disorders Disorders of voice pitch, loudness, or quality.
(12 Dec 1998)
respiration disorders Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
(12 Dec 1998)
gonadal disorders Disease of the ovaries and testes of any aetiology.
(12 Dec 1998)
perceptual disorders Disturbances in recognizing and interpreting sensory stimuli dependent upon one's previous experience.
(12 Dec 1998)
mental disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behaviour producing either distress or impairment of function.
(12 Dec 1998)
mental disorders diagnosed in childhood Those psychiatric disorders usually first diagnosed in infancy, childhood, or adolescence. These disorders can also be first diagnosed during other life stages.
(12 Dec 1998)
child behaviour disorders Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.
(12 Dec 1998)
child development disorders, pervasive Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
(12 Dec 1998)
child nutrition disorders Malnutrition, occurring in children ages 2 to 12 years, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.
(12 Dec 1998)
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
peroxisomal disorders A heterogeneous group of inherited metabolic disorders in which peroxisomes are either defective or totally lacking and/or there is a dysfunction of single or multiple peroxisomal enzymes. Patients show metabolic defects in all the major biosynthetic peroxisomal pathways, especially failure to synthesise ether lipids, or to oxidise long-chain fatty acids, and accumulate bile acid precursors. The disorders include zellweger syndrome, infantile refsum disease, rhizomelic chondrodysplasia (chondrodysplasia punctata, rhizomelic), and hyperpipecolic acidemia.
(12 Dec 1998)
personality disorders A major deviation from normal patterns of behaviour.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á